N/A
Completed N=60
Behavioral Economics to Improve Antihypertensive Therapy Adherence
Hypertension · Medication Adherence
Source: ClinicalTrials.gov NCT04029883 ↗
Enrolled (actual)
60
Serious AEs
0.0%
Results posted
Nov 2023
Primary outcomePrimary: Electronically Measured Mean Medication Adherence During Intervention — 87; 95; 92 Percentage of Timely Med Adherence
Summary
Hypertension represents a major cardiovascular risk factor that can be controlled through the use of medications, yet medication non-adherence represents a common problem that leaves patients at elevated risk for adverse cardiovascular outcomes. Interventions to improve medication adherence have thus far been either unsuccessful or unsustainable. The investigators propose an intervention that leverages insights from behavioral economics to improve medication adherence among hypertensive patients. Strong data indicates that linking the taking of medications to daily routines ('anchoring') increases adherence, however, existing interventions built on this information have failed to create successful, long term improvements in medication adherence. This study aims to leverage behavioral economic insights to improve medication adherence to antihypertensive medications.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Electronically Measured Mean Medication Adherence During Intervention |
87; 95; 92 | — |
| PRIMARY Electronically Measured Mean Medication Adherence Post Intervention |
— | — |
| PRIMARY Routinization of AH Adherence Post-intervention |
— | — |
| SECONDARY Hypertension Control |
— | — |
Eligibility Criteria
Inclusion criteria
- 18 years or older
- On anti-hypertensive medication (AH)
- Own, or have access to a phone at least five days a week throughout the duration of the intervention,
- Willing to receive study text messages
Exclusion criteria
- Under 18 years of age
- Not approved to participate by their provider
- Not willing to use MEMS caps
- Not mentally fit to provide voluntary consent
- Already enrolled in another comparable study
Data sourced from ClinicalTrials.gov (NCT04029883). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.